Covis initiates U.S. asthma inhaler study for COVID-19
Unlisted Covis Pharma B.V.
started a late-stage U.S. randomized trial of its asthma drug
Alvesco in non-hospitalized patients with symptomatic COVID-19,
hoping the inhaled drug treats symptoms and limits viral
replication.
started a late-stage U.S. randomized trial of its asthma drug
Alvesco in non-hospitalized patients with symptomatic COVID-19,
hoping the inhaled drug treats symptoms and limits viral
replication.
Posted by Reuters
